You have been chosen to receive this valuable information.
Do you know what biopharma deals took off in 2018?
Download Report
2018 saw a record-breaking $428B worth of Biopharma deals. Whether you were part of the action or gearing up for 2019 activity, get the latest insights you need for future deals.

In the Cortellis 2018 Deals & Portfolio Review, our analysts dig into the strategies that took off in 2018.

Key topics and trends in the report, include:
  • Big licensing upfronts and mega-M&A: their impact on the industry
  • A closer look at the oncology landscape, which remained the strongest area for deals
  • China's continued emergence as a venue for dealmaking
  • A look at what's ahead for 2019
Download the report today
Want a more in-depth review?

Schedule a meeting with a member of our consulting team today.

Contact us
Clarivate
Accelerating innovation
1500 Spring Garden Street
Fourth Floor‌
Philadelphia
PA 19130 USA‌
© 2019 Clarivate Analytics
Privacy policy
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a UBM publication. You are on the mailing list as %%emailaddress%%.